Clinical Trials Logo

Clinical Trial Summary

Ischemia-reperfusion (IR) injury during liver transplantation is one of the major causes of mortality and morbidity associated with transplantation. Remote organ ischemic preconditioning (RIPC) is one of the most investigated practices to reduce IR injury. In this study, for the first time in the clinic, the effect of RIPC will be evaluated via both systemic inflammation parameters and also parameters showing glycocalyx integrity, on living-donor liver recipients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Ischemia
  • Remote Organ Ischemic Preconditioning

NCT number NCT04216407
Study type Interventional
Source Acibadem University
Contact
Status Completed
Phase N/A
Start date December 5, 2019
Completion date March 20, 2020